Clinical Trial Update: Auditory Control Enhancement (ACE) in Schizophrenia [NA]

View source ↗

Summary

A clinical trial studying Auditory Control Enhancement (ACE) for auditory hallucinations in schizophrenia was terminated and results were posted on 2026-04-07.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Brian A Coffman, PhD | Conditions: Auditory Hallucinations | NA | Status: TERMINATED | Results posted: 2026-04-07